MedTrace Logo

Concentration Impact Nicotine Salt

NCT04725656 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 312

Last updated 2025-03-28

No results posted yet for this study

Summary

Double-blind (for the two active arms), randomized, three-arm (two active and one control) clinical trial investigating factors (e.g. nicotine concentration) influencing the success of smoking cessation strategies and possible health risks related to nicotine salt vaping.

Conditions

  • Smoking Cessation
  • Vaping

Interventions

PROCEDURE

Smoking cessation counseling

Smoking cessation counseling at baseline, week 1, and week 4.

OTHER

Open system vape device and nicotine salt e-liquids

Ad libitum use of nicotine salt e-liquids during three months.

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Evangelia Liakoni, MD · Inselspital, Bern University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04725656 on ClinicalTrials.gov